Commentary: Lifelong prevention of atherosclerosis: The critical importance of major risk factor exposures

International Journal of Epidemiology

Volumn 31, Issue 6, 2002, Pages 1129-1134

  Greenland, Philip ^a   Gidding, Samuel S ^b   Tracy, Russell P ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; DISEASE MODEL; DYSLIPIDEMIA; EXPOSURE; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; IMMOBILIZATION; INFLAMMATION; INSULIN RESISTANCE; LIFESPAN; NOTE; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; RISK FACTOR; SMOKING; WELLBEING;

CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HUMANS; MODELS, CARDIOVASCULAR; RISK FACTORS;

EID: 0036993108     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/31.6.1129     Document Type: Note

References (35)

1. McGill HC Jr, Greer JC, Strong JP. Natural history of human atherosclerotic lesions. In: Standler M, Bourne GH (eds). Atherosclerosis and Its Origin. New York, Academic Press, 1963.
2. Beaglehole R, Magnus P. The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists? Int J Epidemiol 2002;32:1177-22.
3. Kannel WB. The Framingham Study: Its 50-year legacy and future promise. J Atheroscler Thromb 2000;6:60-66.
4. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology 1993;82:191-222.
5. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982;248:1465-77.
6. Greenland P, Deloria-Knoll M, Dyer AR, Garside D. How often does coronary death occur in the absence of traditional risk factors? Presented, 42nd Annual Conference on Cardiovascular Epidemiology and Prevention, American Heart Association, Honolulu, Hawaii, 23-26 April 2002.
7. Marmot M, Winkelstein W Jr. Epidemiologic observations on intervention trials for prevention of coronary heart disease. Am J Epidemiol 1975;101:177-81.
8. Rosenman RH, Friedman M. Neurogenic factors in pathogenesis of coronary heart disease. Med Clin North Am 1974;58:269-79.
9. Kolodgie FD, Burke AP, Farb A et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001;16:285-92.
10. Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 2000;149:251-66.
11. Tracy RP. Inflammation markers and coronary heart disease. Curr Opin Lipidol 1999;10:435-41.
12. Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the 'only-50%' myth. Arch Intern Med 2001;161:2657-60.
13. Barker DJ. A new model for the origins of chronic disease. Med Health Care Philos 2001;4:31-35.
14. McCarron P, Okasha M, McEwen J et al. respond to 'height-cardiovascular disease relation': are all risk factors equal? Am J Epidemiol 2002;155:690-91.
15. McGill HC Jr, McMahan CA, Herderick EE et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-18.
16. Zieske AW, Malcom GT, Strong JP. Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med 2002;21:213-37.
17. McGill HC Jr, McMahan CA, Zieske AW et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000; 20:1998-2004.
18. Gidding SS, Bao W, Srinivasan S, Berenson GS. Effects of secular trends in obesity on coronary risk factors in children: The Bogalusa Heart Study. J Pediatr 1995;127:868-74.
19. Sinaiko AR, Donahue RP, Jacobs DR Jr, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 1999; 99:1471-76.
20. Stuhldreher WL, Orchard TJ, Donahue RP, Kuller LH, Gloninger MF, Drash AL. Cholesterol screening in childhood: sixteen-year Beaver County Lipid Study experience. J Pediatr 1991;119:551-56.
21. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-56.
22. Klag MJ, Ford DE, Mead LA et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993;328:313-18.
23. Navas-Nacher EL, Colangelo L, Beam C, Greenland P. Risk factors for coronary heart disease in men 18 to 39 years of age. Ann Intern Med 2001;134:433-39.
24. McCarron P, Smith GD, Okasha M, McEwen J. Blood pressure in young adulthood and mortality from cardiovascular disease. Lancet 2000;355:1430-31.
25. McCarron P, Smith GD, Okasha M, McEwen J. Smoking in adolescence and young adulthood and mortality in later life: prospective observational study. J Epidemiol Community Health 2001;55:334-35.
26. Stamler J, Stamler R, Neaton JD et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-18.
27. Lagrand WK, Visser CA, Hermens WT et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
28. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996; 144:537-47.
29. Jarvisalo MJ, Harmoinen A, Hakanen M et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002;22:1323-28.
30. Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E, Savage P. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999; 19:1776-83.
31. Cushman M, Lemaitre RN, Kuller LH et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:493-98.
32. Tracy R, Lemaitre R, Psaty B et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-27.
33. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest 1994;93:50-55.
34. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22.
35. Williams CL, Hayman LL, Daniels SR et al. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002;106:143-60.